159
Participants
Start Date
March 30, 2012
Primary Completion Date
October 23, 2019
Study Completion Date
April 23, 2020
Abiraterone Acetate
Given PO
Laboratory Biomarker Analysis
Correlative studies
Prednisone
Given PO
Veliparib
Given PO
Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
UNC Lineberger Comprehensive Cancer Center, Chapel Hill
Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis
University of Michigan Comprehensive Cancer Center, Ann Arbor
University of Wisconsin Women's Health Center, Madison
University of Wisconsin Hospital and Clinics, Madison
NorthShore University HealthSystem-Evanston Hospital, Evanston
University of Chicago Comprehensive Cancer Center, Chicago
M D Anderson Cancer Center, Houston
USC / Norris Comprehensive Cancer Center, Los Angeles
City of Hope Comprehensive Cancer Center, Duarte
City of Hope South Pasadena, South Pasadena
University of Washington Medical Center, Seattle
Rutgers Cancer Institute of New Jersey, New Brunswick
National Cancer Institute (NCI)
NIH